Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1

SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1

US Patent 8198255 · Granted Jun 12, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and metho2025
Radiation mitigator and method of use thereof2025
Radiation mitigator and method of use thereof2025
Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and metho2024
Radiation mitigator and method of use thereof2023
Radiation mitigator and method of use thereof2023
Anti-doublecortin-like kinase 1 antibodies and methods of use2023
Anti-doublecortin-like kinase 1 antibodies and methods of use2023
Radiation mitigator and method of use thereof2022
Radiation mitigator and method of use thereof2022
Anti-DCLK1 monoclonal antibodies and methods of production and use thereof2017
Anti-DCLK1 monoclonal antibodies and methods of production and use thereof2017